Mangalam Drugs and Organics Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹67.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 15.26 per cent from ₹58.38 crore. This corresponds to a year-on-year *(YoY) decline of 7.54 per cent.
Operating Profit
Operating Profit stands at ₹-5.62 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 264.94 per cent from ₹-1.54 crore. This corresponds to a year-on-year *(YoY) decline of 156.77 per cent.
PBDT
PBDT stands at ₹-8.61 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 60.04 per cent from ₹-5.38 crore. This corresponds to a year-on-year *(YoY) decline of 236.02 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-13.27 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 34.86 per cent from ₹-9.84 crore. This corresponds to a year-on-year *(YoY) decline of 914.11 per cent.
Net Profit
Net Profit stands at ₹-13.42 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 36.38 per cent from ₹-9.84 crore. This represents a 22,466.67 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Mangalam Drugs and Organics Ltd News
Mangalam Drugs and Organics Ltd Earnings
- YOY
- QOQ
Mangalam Drugs and Organics Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Mangalam Drugs and Organics Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Mangalam Drugs and Organics Ltd Financial Reports
Mangalam Drugs and Organics Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Mangalam Drugs | 2.54% | 6.43% | 13.26% | 2.21% | -21.16% | -60.05% |
| Vivo Bio Tech | 4.30% | 1.23% | -2.07% | -0.07% | -8.94% | -26.11% |
| Kabra Drugs | 4.14% | 3.64% | -3.47% | -17.99% | -8.48% | 122.61% |
| Phaarmasia | 4.91% | -0.78% | -18.67% | -8.51% | 72.04% | 200.51% |
| Biofil Chemicals | -2.18% | -3.73% | -8.04% | -9.38% | -18.39% | -31.91% |
| Goldline Pharmaceutical | -4.99% | -9.72% | -9.72% | -9.72% | -9.72% | -9.72% |
| Veerhealth Care | 0.64% | 4.68% | 16.81% | 17.57% | 35.39% | 71.33% |
Company Info
Company Information
Chairman / Executive Director / Managing Director : Govardhan M Dhoot
E D & Wholetime Director : Brijmohan Dhoot
Independent Non Exe. Director : Nidhi S. Mundada
Independent Non Exe. Director : Praveen Saxena
Non-Exec & Non-Independent Dir : Rakesh K. Milwani